Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumours (MK-7902-005/E7080-G000-224/LEAP-005)

Trial Centre Location Province Status
CancerCare Manitoba Winnipeg Manitoba Recruiting
Hamilton Health Sciences Hamilton Ontario Recruiting
Princess Margaret Cancer Centre Toronto Ontario Recruiting
Sunnybrook Health Sciences Centre Toronto Ontario Recruiting
CHU de Québec - Université Laval - L'Hôtel-Dieu de Québec Quebec Quebec Recruiting

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.

Resources

Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society